Clinical Trial Update: Role of the Microparticles and of Tissue Factor in the Pro-thrombotic Phenotype and the Thromboembolic Complications During the Acute Lymphoblastic Leukemia in Children. [NA]

View source ↗

Summary

ClinicalTrials.gov entry for NCT02862652 reports a completed study investigating the role of microparticles and tissue factor in the pro-thrombotic phenotype an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Snippet

Sponsor: CHU de Reims | Conditions: Acute Lymphoblastic Leukemia | NA | Status: COMPLETED